@article{ref1,
title="Reducing the harms of xylazine: clinical approaches, research deficits, and public health context",
journal="Harm reduction journal",
year="2023",
author="Zagorski, Claire M. and Hosey, Rebecca A. and Moraff, Christopher and Ferguson, Aaron and Figgatt, Mary and Aronowitz, Shoshana and Stahl, Natalie E. and Hill, Lucas G. and McElligott, Zoe and Dasgupta, Nabarun",
volume="20",
number="1",
pages="e141-e141",
abstract="Xylazine has emerged as a consistent part of the unregulated drug supply in recent months. We discuss major domains of xylazine's harm, current knowledge deficits, clinical and harm reduction strategies for minimizing harm, and xylazine's public health and policy context. As an interdisciplinary team from across the USA, we have pooled our knowledge to provide an overview of xylazine's current and emerging contexts.<p /> <p>Language: en</p>",
language="en",
issn="1477-7517",
doi="10.1186/s12954-023-00879-7",
url="http://dx.doi.org/10.1186/s12954-023-00879-7"
}